nivolumab
bms
['nivo', 'rcc,(-irccs),(-srcc),(-urcc)', 'dance']
post-hoc analysis of prosper (nephrectomy +/- peri-op nivo x9 cycles):
evaluation of 558 pre-op rmbs rmb aes: 2.3% 41/819 pts had non-rcc histologies--&gt; rmb detected only 26/41 concordance btwn rmb and primary tumor path for histologic subtype: kappa=0.62 #asco23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @MCG_Urology and @AUB_Lebanon 🇱🇧